279 related articles for article (PubMed ID: 12937771)
1. Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations.
Paláu MT; Mejía AJ; Vergara U; Zúñiga CA
Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):543-8. PubMed ID: 12937771
[TBL] [Abstract][Full Text] [Related]
2. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice.
Basso B; Moretti ER; Vottero-Cima E
Am J Trop Med Hyg; 1991 Apr; 44(4):413-9. PubMed ID: 1828328
[TBL] [Abstract][Full Text] [Related]
3. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
Introini MV; Basso B; Moretti E
Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection.
Basso B; Moretti E; Fretes R
Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):370-4. PubMed ID: 18660992
[TBL] [Abstract][Full Text] [Related]
5. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi.
Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA
Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704
[TBL] [Abstract][Full Text] [Related]
7. Immunoparasitological studies of Trypanosoma cruzi low virulence clones from Panama: humoral immune responses and antigenic cross-reactions with Trypanosoma rangeli in experimentally infected mice.
Saldaña A; Sousa OE; Orn A
Scand J Immunol; 1995 Dec; 42(6):644-50. PubMed ID: 8552988
[TBL] [Abstract][Full Text] [Related]
8. Can we heal Chagas infection?
Vega Royero SP; Sibona GJ
J Theor Biol; 2014 Jan; 340():23-9. PubMed ID: 24029157
[TBL] [Abstract][Full Text] [Related]
9. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
Basso B; Marini V
Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi: both chemically induced and triatomine-derived metacyclic trypomastigotes cause the same immunological disturbances in the infected mammalian host.
Lopes MF; Cunha JM; Bezerra FL; Gonzalez MS; Gomes JE; Lapa e Silva JR; Garcia ES; Dos Reis GA
Exp Parasitol; 1995 Mar; 80(2):194-204. PubMed ID: 7895831
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with Trypanosoma rangeli induces resistance of guinea pigs to virulent Trypanosoma cruzi.
Basso B; Moretti E; Fretes R
Vet Immunol Immunopathol; 2014 Jan; 157(1-2):119-23. PubMed ID: 24275040
[TBL] [Abstract][Full Text] [Related]
12. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to metacyclic stage antigens of Trypanosoma cruzi.
Chao D; Dusanic DG
Am J Trop Med Hyg; 1985 Jul; 34(4):694-701. PubMed ID: 3927760
[TBL] [Abstract][Full Text] [Related]
14. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: properties of a clone isolated from CL strain.
Lima MT; Jansen AM; Rondinelli E; Gattass CR
Parasitol Res; 1991; 77(1):77-81. PubMed ID: 1899726
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.
Hunter CA; Slifer T; Araujo F
Infect Immun; 1996 Jul; 64(7):2381-6. PubMed ID: 8698455
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi.
Basso B; Castro I; Introini V; Gil P; Truyens C; Moretti E
Vaccine; 2007 May; 25(19):3855-8. PubMed ID: 17349724
[TBL] [Abstract][Full Text] [Related]
18. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
Wallace A; Sanchez G; Venegas J; Solari A
Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
Saldaña A; Sousa OE
J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
[TBL] [Abstract][Full Text] [Related]
20. Absence of experimental cross-protection induced by a Trypanosoma cruzi-like strain isolated from bats.
Nascentes GA; Meira WS; Lages-Silva E; Ramírez LE
Rev Soc Bras Med Trop; 2008; 41(2):152-7. PubMed ID: 18545835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
